Kerala Children Suffer Due to Ineffective Insulin

Children diagnosed with Type I diabetes in Kerala are reportedly suffering adverse health effects, including diabetic ketoacidosis, attributed to a change in insulin provided by the state's Mittayi clinics. The Type One Diabetes Foundation (Kerala) has petitioned the Chief Minister, stating that the insulin supplied over the past year is ineffective compared to the previous rapid-acting formulation.

The foundation alleges that the current slow-acting insulin disrupts children's daily routines, causing them to miss lunch breaks at school and struggle with blood sugar management. This necessitates more frequent doses without achieving adequate control, leading to visible issues like involuntary urination in class for younger children. Hospitalizations have occurred, with medical professionals advising discontinuation of the current insulin.

Families of children benefiting from the Mittayi scheme find it financially impossible to procure the previously used rapid-acting insulin independently. Despite reports that government financial constraints led to the switch, the foundation emphasizes that the health of these children, who rely on the Mittayi scheme as a model for other states, must be prioritized. The commission for the protection of child rights has also been petitioned for swift action.